Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis

Alpha-1 antitrypsin deficiency is an inherited disease that affects the lung and the liver. Carrying two severely dysfunctional copies of the alpha-1 antitrypsin gene may cause advanced chronic liver disease/cirrhosis. Affected individuals with a first complication of cirrhosis are more prone to developing further liver-related events (including multiorgan dysfunction) and requiring liver transplantation (which cures the inherited liver disease) compared to patients who have similarly advanced liver disease. These findings should prompt the development of disease-modifying treatments and early listing for liver transplantation.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-03-20
DOI
https://doi.org/10.1016/j.jhepr.2025.101398
Citations
2
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
2.64

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis

Mattias Mandorfer, Malin Fromme, Martin Wagner, Pavel Strnad et al.
2 citations
JHEP Reports
Liver Disease and Transplantation
2.64
article

Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosis

Mattias Mandorfer, Malin Fromme, Martin Wagner, Pavel Strnad, Benjamin Maasoumy, Mònica Pons, Jef Verbeek, Jan Stolk, Lukas Van Melkebeke, Tammo Lambert Tergast, Georg Semmler, Markus Peck‐Radosavljevic, Thomas Reiberger, Benedikt Silvester Hofer, Jan Šperl, Mathias Jachs, Michael A Trauner, Bart van Hoek, Soňa Fraňková, Naomi Kappe, Lorenz Balcar, Benedikt Schaefer, Harald Hofer, Anna Sophie Karl, Heinz Zoller, Hannah Rieland
article en
2 citations

Abstract

Alpha-1 antitrypsin deficiency is an inherited disease that affects the lung and the liver. Carrying two severely dysfunctional copies of the alpha-1 antitrypsin gene may cause advanced chronic liver disease/cirrhosis. Affected individuals with a first complication of cirrhosis are more prone to developing further liver-related events (including multiorgan dysfunction) and requiring liver transplantation (which cures the inherited liver disease) compared to patients who have similarly advanced liver disease. These findings should prompt the development of disease-modifying treatments and early listing for liver transplantation.

JHEP ReportsVol. 7(6)
Universitat Autònoma de Barcelona (ES), Innsbruck Medical University (AT), Universität Innsbruck (AT), Medical University of Graz (AT), Leiden University Medical Center (NL), Medizinische Hochschule Hannover (DE), Klinikum Klagenfurt (AT), Vall d'Hebron Institut de Recerca (ES), Klinikum Wels-Grieskirchen (AT), Vall d'Hebron Hospital Universitari (ES), ERN GUARD-Heart (NL), Medical University of Vienna (AT), RWTH Aachen University (DE), KU Leuven (BE)
CSL Behring, Deutsche Forschungsgemeinschaft, RWTH Aachen University, Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
Zero hunger
Openalex Percentile: Top 12%
Liver Disease and Transplantation
2.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.